Sr. Financial Analyst

United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Clinical Trials, Healthcare TechnologyIndustries

Requirements

Candidates must possess a Bachelor's Degree in Accounting, Finance, or a related field, with a minimum of 8 years of progressive management experience in financial planning and analysis. An MBA or CPA is considered a plus. Strong analytical skills, prior experience with M&A transactions, and familiarity with foreign currency accounting and large data manipulation are required. Proficiency in Excel, Word, and Access is essential, and working knowledge of FDA regulations is preferred. Excellent verbal and written communication, attention to detail, and strong organizational skills are also necessary.

Responsibilities

The Sr. Financial Analyst will serve as a key financial business partner for assigned segments, assisting with comprehensive forecasting, trend analysis, and monitoring performance indicators. Responsibilities include investigating discrepancies, managing budgets, building cost models for profit margin analysis, and preparing ad hoc financial reports. The role also involves participating in corporate financial analysis, mergers and acquisitions efforts, and pricing structure analysis. Additionally, the analyst will guide accounting and finance projects, support the CFO, and contribute to departmental standards and process improvements.

Skills

Financial Analysis

Forecasting

Trend Analysis

Budgeting

Cost Modeling

Mergers and Acquisitions

Due Diligence

Pricing Analysis

Profit Margin Analysis

Ad hoc Reporting

Financial Planning

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free